Literature DB >> 32354387

Extracellular Matrix in Ischemic Heart Disease, Part 4/4: JACC Focus Seminar.

Nikolaos G Frangogiannis1, Jason C Kovacic2.   

Abstract

Myocardial ischemia and infarction, both in the acute and chronic phases, are associated with cardiomyocyte loss and dramatic changes in the cardiac extracellular matrix (ECM). It has long been appreciated that these changes in the cardiac ECM result in altered mechanical properties of ischemic or infarcted myocardial segments. However, a growing body of evidence now clearly demonstrates that these alterations of the ECM not only affect the structural properties of the ischemic and post-infarct heart, but they also play a crucial and sometimes direct role in mediating a range of biological pathways, including the orchestration of inflammatory and reparative processes, as well as the pathogenesis of adverse remodeling. This final part of a 4-part JACC Focus Seminar reviews the evidence on the role of the ECM in relation to the ischemic and infarcted heart, as well as its contribution to cardiac dysfunction and adverse clinical outcomes.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  biomarker; collagen; fibroblast; heart failure; ischemic heart disease

Mesh:

Substances:

Year:  2020        PMID: 32354387      PMCID: PMC7269147          DOI: 10.1016/j.jacc.2020.03.020

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  207 in total

1.  Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.

Authors:  Michael P Hudson; Paul W Armstrong; Witold Ruzyllo; Jose Brum; Lisa Cusmano; Piotr Krzeski; Robert Lyon; Miguel Quinones; Pierre Theroux; Diana Sydlowski; Henry E Kim; Mario J Garcia; Wael A Jaber; W Douglas Weaver
Journal:  J Am Coll Cardiol       Date:  2006-06-21       Impact factor: 24.094

2.  Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2.

Authors:  Wenjie Wang; Grzegorz Sawicki; Richard Schulz
Journal:  Cardiovasc Res       Date:  2002-01       Impact factor: 10.787

3.  Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction.

Authors:  Fatih Arslan; Mirjam B Smeets; Paul W Riem Vis; Jacco C Karper; Paul H Quax; Lennart G Bongartz; John H Peters; Imo E Hoefer; Pieter A Doevendans; Gerard Pasterkamp; Dominique P de Kleijn
Journal:  Circ Res       Date:  2011-02-24       Impact factor: 17.367

4.  Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.

Authors:  M S O'Reilly; T Boehm; Y Shing; N Fukai; G Vasios; W S Lane; E Flynn; J R Birkhead; B R Olsen; J Folkman
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

5.  Extracellular matrix remodeling in canine and mouse myocardial infarcts.

Authors:  M Dobaczewski; M Bujak; P Zymek; G Ren; M L Entman; N G Frangogiannis
Journal:  Cell Tissue Res       Date:  2006-02-22       Impact factor: 5.249

Review 6.  Molecular control of capillary morphogenesis and maturation by recognition and remodeling of the extracellular matrix: functional roles of endothelial cells and pericytes in health and disease.

Authors:  George E Davis; Pieter R Norden; Stephanie L K Bowers
Journal:  Connect Tissue Res       Date:  2015-08-25       Impact factor: 3.417

7.  Extracellular matrix turnover biomarkers predict long-term left ventricular remodeling after myocardial infarction: insights from the REVE-2 study.

Authors:  Romain Eschalier; Marie Fertin; Renaud Fay; Christophe Bauters; Faïez Zannad; Florence Pinet; Patrick Rossignol
Journal:  Circ Heart Fail       Date:  2013-08-27       Impact factor: 8.790

8.  Sequential changes in the distribution of type I and III collagens in the infarct zone: immunohistochemical study of experimental myocardial infarction in the rat.

Authors:  K Inoue; S Kusachi; K Niiya; Y Kajikawa; T Tsuji
Journal:  Coron Artery Dis       Date:  1995-02       Impact factor: 1.439

9.  Trends in the clinical and pathological characteristics of cardiac rupture in patients with acute myocardial infarction over 35 years.

Authors:  Satoshi Honda; Yasuhide Asaumi; Takafumi Yamane; Toshiyuki Nagai; Tadayoshi Miyagi; Teruo Noguchi; Toshihisa Anzai; Yoichi Goto; Masaharu Ishihara; Kunihiro Nishimura; Hisao Ogawa; Hatsue Ishibashi-Ueda; Satoshi Yasuda
Journal:  J Am Heart Assoc       Date:  2014-10-20       Impact factor: 5.501

10.  Matricellular proteins: an overview.

Authors:  Paul Bornstein
Journal:  J Cell Commun Signal       Date:  2009-09-25       Impact factor: 5.782

View more
  10 in total

Review 1.  Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction.

Authors:  Harikrishnan Venugopal; Anis Hanna; Claudio Humeres; Nikolaos G Frangogiannis
Journal:  Cells       Date:  2022-04-20       Impact factor: 7.666

2.  Three-dimensional unity of engineered heart tissue mimics the heart better than two-dimensional cellular diversity.

Authors:  Charan Thej; Grace Huang; Raj Kishore
Journal:  Cardiovasc Res       Date:  2021-07-27       Impact factor: 10.787

Review 3.  Cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

4.  Positron Emission Tomography (PET) with 18F-FGA for Diagnosis of Myocardial Infarction in a Coronary Artery Ligation Model.

Authors:  Vibhudutta Awasthi; Hariprasad Gali; Andria F Hedrick; Huining Da; Venkateswararao Eeda; Diwakar Jain
Journal:  Mol Imaging       Date:  2022-02-09       Impact factor: 4.488

5.  Injectable conductive gelatin methacrylate / oxidized dextran hydrogel encapsulating umbilical cord mesenchymal stem cells for myocardial infarction treatment.

Authors:  Shuoji Zhu; Changjiang Yu; Nanbo Liu; Mingyi Zhao; Zerui Chen; Jian Liu; Ge Li; Huanlei Huang; Huiming Guo; Tucheng Sun; Jimei Chen; Jian Zhuang; Ping Zhu
Journal:  Bioact Mater       Date:  2021-11-17

Review 6.  Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies.

Authors:  Stefan Frantz; Moritz Jens Hundertmark; Jeanette Schulz-Menger; Frank Michael Bengel; Johann Bauersachs
Journal:  Eur Heart J       Date:  2022-07-14       Impact factor: 35.855

Review 7.  Immune Cells and Immunotherapy for Cardiac Injury and Repair.

Authors:  Joel G Rurik; Haig Aghajanian; Jonathan A Epstein
Journal:  Circ Res       Date:  2021-05-27       Impact factor: 23.213

Review 8.  Engineering Myocardium for Heart Regeneration-Advancements, Considerations, and Future Directions.

Authors:  Dillon K Jarrell; Ethan J Vanderslice; Mitchell C VeDepo; Jeffrey G Jacot
Journal:  Front Cardiovasc Med       Date:  2020-10-15

9.  Creating a Natural Vascular Scaffold by Photochemical Treatment of the Extracellular Matrix for Vascular Applications.

Authors:  Katalin Kauser; Kevin S Warner; Blake Anderson; Edgar Dalles Keyes; R B Hayes; Eric Kawamoto; D H Perkins; Robert Scott; Jim Isaacson; Barb Haberer; Ann Spaans; Ronald Utecht; Hank Hauser; Andrew George Roberts; Myles Greenberg
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

Review 10.  Cell therapy in patients with heart failure: a comprehensive review and emerging concepts.

Authors:  Roberto Bolli; Mitesh Solankhi; Xiang-Liang Tang; Arunpreet Kahlon
Journal:  Cardiovasc Res       Date:  2022-03-16       Impact factor: 10.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.